Sign Up Today and Learn More About SirionLabs Stock
Invest in or calculate the value of your shares in SirionLabs or other pre-IPO companies through EquityZen's platform.
SirionLabs Stock (SILA)
Contract Lifecycle Management Platform
About SirionLabs Stock
Founded
2012
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
SirionLabs is a provider of a SaaS enterprise contract management (CLM) platform for enterprises to manage the complete contracting lifecycle. Key innovations include AI-led contract authoring, automated obligation extraction, real-time service level computation and predictive invoicing on a permissioned ledger architecture to promote true buyer-supplier collaboration and reduce leakage.
SirionLabs Press Mentions
Stay in the know about the latest news on SirionLabs
Sirion Named a Leader in Industry Evaluation of Contract Lifecycle Management Platforms
businesswire • Feb 25, 2025
Sirion Ranks Highest in All Four Use Cases in 2024 Gartner® Critical Capabilities for Contract Life Cycle Management
businesswire • Oct 31, 2024
Sirion Wins the 2024 Oracle Partner Awards - APAC Innovation Category
morningstar • Sep 14, 2024
Sirion’s Acquisition of Eigen Technologies Boosts Document AI Capabilities
aithority • Aug 03, 2024
Data Vantage: BIOBOT Surgical, Sirion, ESQA, Tyme and GDMC in focus
dealstreetasia • Jul 04, 2024
Investors in SirionLabs
Discover investors in SirionLabs stock and explore their portfolio companies
SirionLabs Management
Leadership team at SirionLabs
Chief Executive Officer
Ajay Agrawal
Chief Technology Officer
Anu Engineer
Join now and verify your accreditation status to gain access to:
- SirionLabs Current Valuation
- SirionLabs Stock Price
- SirionLabs Management
- Available deals in SirionLabs and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- SirionLabs Cap Table and Funding History by Share Class and Liquidity Preferences
- SirionLabs Revenue and Financials
- SirionLabs Highlights
- SirionLabs Business Model
- SirionLabs Risk Factors
- SirionLabs Research Report from SACRA Research
Trading SirionLabs Stock
How to invest in SirionLabs stock?
Accredited investors can buy pre-IPO stock in companies like SirionLabs through EquityZen funds. These investments are made available by existing SirionLabs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell SirionLabs stock?
Shareholders can sell their SirionLabs stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
